Literature DB >> 20583867

Abdominal wall infections with in situ mesh.

Richard D Collage1, Matthew R Rosengart.   

Abstract

BACKGROUND: Synthetic mesh is used commonly in the repair of abdominal wall hernias. Infection at the surgical site where mesh is present poses a formidable clinical problem.
METHODS: The current surgical literature was reviewed to formulate accepted approaches to the management of hernia repairs with infected mesh.
RESULTS: Prevention of mesh infection is best achieved by judicious use of systemic antibiotics. Topical antibiotics often are used without convincing evidence to support their value. Laparoscopic repairs have lower infection rates than open repairs. Evidence is lacking to support lower rates of infection with mesh of specific composition or with antibacterial agents that coat the mesh. The diagnosis of mesh infection is principally a clinical one. Repairs of infected mesh usually necessitate antibiotics and removal of the foreign material. Clinical judgment is required for attempts at salvaging portions of the mesh. Component separation or biological materials may be used in those circumstances for hernia repair in which large defects are created by removal of the infected synthetic material.
CONCLUSIONS: Prevention of mesh infections remains the best strategy. Clinical judgment is essential in determining the degree of mesh removal. Continued clinical studies are necessary to improve the outcomes of established mesh infection in hernia repairs.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20583867     DOI: 10.1089/sur.2010.029

Source DB:  PubMed          Journal:  Surg Infect (Larchmt)        ISSN: 1096-2964            Impact factor:   2.150


  8 in total

Review 1.  Surgical mesh for ventral incisional hernia repairs: Understanding mesh design.

Authors:  Ali Rastegarpour; Michael Cheung; Madhurima Vardhan; Mohamed M Ibrahim; Charles E Butler; Howard Levinson
Journal:  Plast Surg (Oakv)       Date:  2016       Impact factor: 0.947

2.  Gentamicin for prevention of intraoperative mesh contamination: demonstration of high bactericide effect (in vitro) and low systemic bioavailability (in vivo).

Authors:  A Wiegering; B Sinha; L Spor; U Klinge; U Steger; C T Germer; U A Dietz
Journal:  Hernia       Date:  2014-08-12       Impact factor: 4.739

Review 3.  [Management of mesh-related infections].

Authors:  U A Dietz; L Spor; C-T Germer
Journal:  Chirurg       Date:  2011-03       Impact factor: 0.955

4.  Evaluation of human acellular dermis versus porcine acellular dermis in an in vivo model for incisional hernia repair.

Authors:  Manh-Dan Ngo; Harold M Aberman; Michael L Hawes; Bryan Choi; Arthur A Gertzman
Journal:  Cell Tissue Bank       Date:  2011-03-06       Impact factor: 1.522

5.  Oral, intestinal, and skin bacteria in ventral hernia mesh implants.

Authors:  Odd Langbach; Anne Karin Kristoffersen; Emnet Abesha-Belay; Morten Enersen; Ola Røkke; Ingar Olsen
Journal:  J Oral Microbiol       Date:  2016-07-29       Impact factor: 5.474

6.  Long-term outcome of biologic graft: a case report.

Authors:  Kim-Phung Nguyen; Veronica Zotos; Eddy C Hsueh
Journal:  J Med Case Rep       Date:  2014-07-17

Review 7.  Evidence for Replacement of an Infected Synthetic by a Biological Mesh in Abdominal Wall Hernia Repair.

Authors:  Agneta Montgomery; Friedrich Kallinowski; Ferdinand Köckerling
Journal:  Front Surg       Date:  2016-01-08

8.  Biodegradable rifampicin-releasing coating of surgical meshes for the prevention of bacterial infections.

Authors:  Jochen Reinbold; Teresa Hierlemann; Lukas Urich; Ann-Kristin Uhde; Ingrid Müller; Tobias Weindl; Ulrich Vogel; Christian Schlensak; Hans Peter Wendel; Stefanie Krajewski
Journal:  Drug Des Devel Ther       Date:  2017-09-18       Impact factor: 4.162

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.